Author Archives: admin


HRMC to open hematology and oncology clinic – The Ottawa Herald

On Aug. 4, Hutchinson Regional Medical Center will open the Hutchinson Hematology and Oncology clinic. Dr. Sawsan Amireh will join the Hutch Regional team that day and see her first patients at her clinic which will be located in Suite 4 of Doctors Park at 2100 N. Waldron St., a building located to the southwest of the main hospital campus on the east side of Waldron Street.

Hematology and Oncology are two branches of medicine that continue to be a concern of members of our community and throughout the State of Kansas.

Oncology is the branch of medical science dealing with tumors, including the diagnosis and treatment of cancer. More than 1.8 million Americans, including 16,000 Kansans, are diagnosed with cancer each year. For more than 600,000 of our nations population each year, cancer is a terminal disease. The good news is that 17 million Americans are living out their lives as cancer survivors.

Cancer is best defined as the uncontrolled growth and spread of abnormal cells and the cause is often attributed to everything from heredity to an unhealthy lifestyle including tobacco use and excess weight. Treatments are medical, surgical, Chemotherapy and Radiation.

Hematology is the branch of medicine dealing with the cause, treatment and prevention of disease related to the blood. Specific issues dealt with include treatment of bleeding disorders, Lymphoma and Leukemia and blood transfusions, along with bone marrow and stem cell transplants.

Dr. Amireh, who has received training on the latest treatment protocols, arrives at Hutch Regional with impeccable credentials and is Board Certified in Internal Medicine. She received her doctorate degree in 2011 from the University of Jordan School of Medicine in Amman, Jordan. Since 2017, Dr. Amireh has participated in a Hematology and Oncology Fellowship and also served as chief fellow with the State University of New York Downstate Health Science Center in Brooklyn, New York. Also, Dr. Amireh served as Associate Chief Medical Resident and Internal Medical Resident at Saint Michaels Medical Center in New Jersey.

In 2010, Dr. Amireh completed special training at Vanderbilt University Medical Center in Nashville, Tennessee on Hepatology and Pediatric Endocrinology. She has won numerous awards and honors including the Clinical Documentation Excellence Award from St. Michaels Medical Center, the Academic Excellence Award from the University of Jordan School of Medicine, and the English Talented Writing Award from the University of Jordan.

Dr. Amireh is a member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians, and the Jordan Medical Association.

Dr. Amireh said Oncology has entered a new era with the onset of COVID-19. "Cancer patients are now more vulnerable and will need to be more diligent to avoid infection which proves that life is more fragile than it once was," Dr. Amireh said. "I am looking forward to starting a hospital-based practice. We have a young family and southcentral Kansas is a good place to raise a two-year old. New York is too busy and not really family friendly."

"I want my practice to be inclusive and will welcome everyone who needs treatment and care," Dr. Amireh continued.

Appointments with Dr. Amireh will be accepted starting in Mid-July. Additional information including her clinics contact information will be published at that time.

With the opening of Hutchinson Hematology and Oncology, south central and western Kansas will have a new choice for quality cancer care. Dr. Amireh will provide a caring, personal approach to cancer care and her clinic will work in tandem with the Chalmers Cancer Center and the other Hutchinson Regional Healthcare System entities as well as other physician specialties in Hutchinson and surrounding communities to provide an integrated approach to care in Hutchinson.

Dr. Amireh will join her spouse, Dr. Mohammed "Mo" Al-Halawani at Hutch Regional. In July 2019, Dr. Al-Halawani joined Dr. Tariq Musa in opening Hutchinson Pulmonology Associates at Hutchinson Regional Medical Center. Dr. Al-Halawani and Dr. Musa hit the ground running and are serving patients in Hutchinson as well as an outreach clinic in McPherson, with plans to support pulmonary needs locally and in the surrounding areas.

We are excited that these high caliber healthcare professionals have chosen to move across America to provide their expertise to residents on the plains of Kansas.

Ken Johnson is the President and CEO of Hutchinson Regional Medical Center.

See the original post here:
HRMC to open hematology and oncology clinic - The Ottawa Herald

Gift of Life, Root and Rutgers Researchers Launch COVID-19 Study – Patch.com

This post was contributed by a community member. The views expressed here are the author's own.

Boca Raton, FL, June 29 Human leukocyte antigens (HLA) diverse genetic markers on our cells that help match patients and donors for bone marrow transplant are the focus of a new study led by the Gift of Life Marrow Registry.

The study, in collaboration with researchers at Rutgers Cancer Institute of New Jersey and the genetic crowd science portal Root, aims to help answer a key question: why do some people get COVID19 or particular symptoms, while others avoid them? More than 350,000 donors in Gift of Life's registry have been invited to participate, helping researchers answer this important question.

"Every volunteer donor is already HLA-typed, presenting a tremendous opportunity to drive broader science through the prism of these immune-related genes," said Gift of Life's Founder and CEO Jay Feinberg. "We're excited to help the world understand how our immune systems may shape the pandemic."

"We hope to learn whether immune-vital tissue match genes such as HLA help explain why some of us avoid COVID-19, while others get severe symptoms or need particular treatments," said the study's principal investigator Jeffrey Rosenfeld, PhD, Assistant Professor of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School. "Adding such key data to the fight against COVID-19, we can help solve the mystery of why it affects different people so differently."

Subscribe

Root's founder, geneticist Nathaniel Pearson, PhD, noted that "because transplant registries read HLA genes better than consumer DNA tests do, a study like this can best reveal how these diverse, immune-vital genes may shape COVID-19. Gift of Life members, who have long saved lives via transplants, now show us how everyday people can help the world beat a pandemic too."

Participants can also opt into short monthly surveys for the coming year, even if they have never had COVID-19. The researchers will study their de-identified data, to better understand how tissue match genes and other factors may figure in COVID-19 risks and outcomes.

Subscribe

The new study furthers Gift of Life's efforts to help people and communities in need during the pandemic. The organization has increased capacity at the Dr. Miriam and Sheldon G. Adelson Gift of LifeBe The Match Collection Center to become a non-hospital based go-to for stem cell donations and contributed 10,000 specialized swabs to Baptist Health South Florida via Boca Raton Regional Hospital to be used for COVID-19 testing.

About Gift of Life Marrow Registry The Gift of Life Marrow Registry is a 501(c)(3) nonprofit organization headquartered in Boca Raton, Fla. The organization, established in 1991, is dedicated to saving lives by facilitating bone marrow and blood stem cell transplants for patients with leukemia, lymphoma, and other blood-related diseases. To learn more about Gift of Life or to make a tax-deductible donation, visit http://www.giftoflife.org.

About Rutgers Cancer Institute of New Jersey As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including bone marrow transplantation, proton therapy, CAR T-cell therapy and complex robotic surgery. Along with clinical trials and novel therapeutics such as precision medicine and immunotherapy many of which are not widely available patients have access to these cutting-edge therapies at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as through RWJBarnabas Health facilities.

Along with world-class treatment, which is often fueled by on-site research conducted in Rutgers Cancer Institute laboratories, patients and their families also can seek cancer preventative services and education resources throughout the Rutgers Cancer Institute and RWJBarnabas Health footprint statewide. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit http://www.cinj.org/giving.

About Root

Root (rootdeep.com) works to grow, diversify, and engage the ranks of blood and marrow volunteers earth's biggest group of living, contactable DNA data owners to save patients in need, honor their good will with good insights, and empower them to spark broader health science discoveries with researchers.

The views expressed in this post are the author's own. Want to post on Patch? Register for a user account.

Patch is a space for neighborhood news. Please keep your replies clean, friendly and factual. Read our community guidelines here

Reply to this articleReply

Read the original post:
Gift of Life, Root and Rutgers Researchers Launch COVID-19 Study - Patch.com

Obituaries in the Sunday and Monday Courier, June 28-29 – Waterloo Cedar Falls Courier

DENVER Irene M. Hillson, 97, of Denver, formerly of Waterloo, died Thursday, June 25, at home.

She was born Nov. 15, 1922, in Iowa, daughter of Albert K. and Hilda A. Klooster Johnson. She married Robert G. Bob Todd Hillson on June 1, 1946, in Blue Earth, Minn.; he died Feb. 21, 2009.

She worked as a family assistant for many families at nursing homes and private homes.

Survivors: a son, Daris Hillson of Waterloo; two daughters, Adri (Bob) Lang of Denver, and Betty Otting of Waterloo; four grandchildren, James (Rosie) Hillson, Gregory Jensen, Kendra (Quinn) Taplin, and Kayla (Bryan) Sinclair; a stepgrandson, Ray Soto; two foster grandchildren, Jennie Love and Mickey Henderson; nine great-grandchildren, Monica Rynearson, Ivy Mae Hillson, Payton Hillson, Cora Jensen, Sawyer Jensen, Alaina Taplin, Nora Taplin, Karah Sinclair, and Brock Sinclair; three stepgreat-grandchildren, Olivia, Gabbie and Sophia Soto; and a sister, Lois Patten of Grinnell.

Preceded in death by: her parents; her husband; a sister, Margaret Wirtjes; and a brother, Raymond Johnson.

Services: 1 p.m. Friday, July 3, at Kearns Funeral Service Kimball Chapel with burial in the Garden of Memories Cemetery, both in Waterloo. Visitation is 5 to 7 p.m. Thursday, and also one hour before the service at the funeral home. The family asks that masks be worn. The service will be recorded and posted to the funeral home website.

Memorials: to the family.

Irene enjoyed visiting with family and friends, caregiving, reading and both flower and vegetable gardening.

Kearns Funeral Service Kimball Chapel is in charge of arrangements (319) 233-3146. Online condolences may be left at http://www.kearnsfuneralservice.com.

As a young woman, Irene felt the conviction to follow the teachings of Jesus and became part of a worldwide fellowship of believers. She remained true to that choice the rest of her life.

See the article here:
Obituaries in the Sunday and Monday Courier, June 28-29 - Waterloo Cedar Falls Courier

Stem Cells Market Analysis Growth Opportunities and Demand Drives by 2016 to 2028 – 3rd Watch News

The report provides insights on opportunities, restraints, drivers, trends, and forecasts up to 2028. As per the over view of the globalStem cells marketthe market was at US$ xx mn in 2019 and is expected grow at a CAGR of xx% over the forecast period 2016 2028. The detailed study of the business of the Stem cells market covers the estimation size of the market in terms of volume and value.

In an attempt to identify the opportunities for growth in the Stem cells market, the industry analysis was geographically divided into significant regions that are progressing faster than the overall market.

Each market player included in the study of Stem cells market is evaluated according to its production footprint, market share, existing and new launches, current R&D projects, and business strategies. Also, the Stem cells market study evaluates the strengths, weaknesses, opportunities and threats (SWOT) analysis. The report evaluates and explores the progress outlook for the global Stem cells market environment, including sales, production & usage and historical data & forecasting.

For more information, download sample of the premium report:https://www.quincemarketinsights.com/request-sample-60762?utm_source=campaign=Pooja/3WN

ThisPress Release will help you to understand the size, growth opportunities with Trends that control the market.

What insights will readers obtain from the report on the Stem cells market?

This report is customized by segment, by sub-segment, by region/country, along with a product specific competitive analysis to meet your specific requirements.

Important objectives of this report are:To estimate the market size for Stem cells market on a regional and global basis, to identify major segments in Stem cells market and evaluate their market shares and demand, to provide a competitive scenario for the Stem cells market with major developments observed by key companies in the historic years, and to evaluate key factors governing the dynamics of the Stem cells market with their potential gravity during the forecast period.

The Key Players mentioned in our report are: BioTime Inc., Cytori Therapeutics, Inc., STEMCELL Technologies Inc., Astellas Pharma Inc., U.S. Stem Cell, Inc., Osiris Therapeutics, Inc., Takara Bio Inc., Caladrius Biosciences, Inc., Cellular Engineering Technologies Inc., BrainStorm Cell Therapeutics Inc.

Get ToC for the overview of the premium report:https://www.quincemarketinsights.com/request-toc-60762?utm_source=campaign=Pooja/3WN

Market Segmentation:

By Product:

Adult Stem Cell

Human Embryonic Stem Cell

Induced Pluripotent Stem Cell

By Sources:

Autologous

Allogeneic

By Application:

Regenerative Medicine

Drug Discovery & Development

By End-Users:

Therapeutic Companies

Cell & Tissues Banks

Tools & Reagent Companies

Service Companies

By Region:

North America

North America, by Country

US

Canada

Mexico

North America, by Product

North America, by Sources

North America, by Application

North America, by End-Users

Western Europe

Western Europe, by Country

Germany

UK

France

Italy

Spain

The Netherlands

Rest of Western Europe

Western Europe, by Product

Western Europe, by Sources

Western Europe, by Application

Western Europe, by End-Users

Asia Pacific

Asia Pacific, by Country

China

India

Japan

South Korea

Australia

Indonesia

Rest of Asia Pacific

Asia Pacific, by Product

Asia Pacific, by Sources

Asia Pacific, by Application

Asia Pacific, by End-Users

Eastern Europe

Eastern Europe, by Country

Russia

Turkey

Rest of Eastern Europe

Eastern Europe, by Product

Eastern Europe, by Sources

Eastern Europe, by Application

Eastern Europe, by End-Users

Middle East

Middle East, by Country

UAE

Saudi Arabia

Qatar

Iran

Rest of Middle East

Middle East, by Product

Middle East, by Sources

iddle East, by Application

Middle East, by End-Users

Rest of the World

Rest of the World, by Country

South America

Africa

Rest of the World, by Product

Rest of the World, by Sources

Rest of the World, by Application

Rest of the World, by End-Users

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us Quince Market Insights Ajay D. (Knowledge Partner) Office No- A109, Pune, Maharashtra 411028 Phone: +91 706 672 5858/+1 208 405 2835/+91 706 672 4848 Email:[emailprotected] Web:www.quincemarketinsights.com

Follow this link:
Stem Cells Market Analysis Growth Opportunities and Demand Drives by 2016 to 2028 - 3rd Watch News

Orthobiologics Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE – Cole of Duty

The Global Orthobiologies Market is expected to exceed more than US$ 10.0 Billion by 2025 at a CAGR of 7.5% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Anthrex, Zimmer Biomet, NuVasive, Inc., Orthofix, Inc., Wright Medical Technology, Globus Medical, Osiris Therapeutics, Inc., Genzyme, DePuy Synthes, Inc., Stryker Corporation, Smith & Nephew plc, Pioneer Surgical Technology, Bioventus LLC, Medtronic, Bone Biologics, Corp. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

You Can Browse Full Report: https://www.marketresearchengine.com/orthobiologics-market

Orthobiologics are the substances that are found in human beings in their body which is used for rapid curing process of wounds and injuries such as injured muscles, ligaments and broken bones. The use of orthobiologics are used in greater concentration, they help in accelerating curing action. The quick curing process, less number of hospital calls and visits, and increased healing are the advantages due to which orthobiologics are achieving importance in present scenario. Innovative technologies in biomaterials, used in the production of orthobiologics assume to increase the market demand. The sector is mainly driven by the growing number of orthopedic methods worldwide as an effect of an upturn in obesity and accidents. The fast increasing population globally, deeply vulnerable to spinal and other orthopedic disorders are also grant to the rising number of orthopedic procedures. These especially include corrections in graft designs, stem cell therapy, cultured tissue scaffolds and advent of recombinant biologic agents. The growth is backed with the benefits such as enlarged biocompatibility, lessened surgical time and smaller incisions. Moreover, these novel arrangements are dared to productively decrease the repeat of post-operative confusions, which consequently is relied upon to support the Orthobiologics market.

The Global Orthobiologies Market is segmented on the lines of its product, application, end-use and regional. Based on product segmentation it covers demineralized bone matrix (DBM), allograft and bone morphogenetic protein (BMP), viscosupplementation, synthetic bone substitutes and stem cell therapy. Based on application segmentation it covers spinal fusion, trauma repair, reconstructive surgery. Based on end-use segmentation it covers hospitals, orthopedic clinics. The Global Orthobiologies Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The scope of the report includes a detailed study of global and regional markets on Global Orthobiologics Market with the reasons given for variations in the growth of the industry in certain regions.

The Global Orthobiologics Market has been segmented as below:

The Global Orthobiologics Market is Segmented on the lines of Product Analysis, Application Analysis, End-Use Analysis and Regional Analysis. By Product Analysis this market is segmented on the basis of Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes and Stem Cell Therapy. By Application Analysis this market is segmented on the basis of Spinal Fusion, Trauma Repair and Reconstructive Surgery.

By End-Use Analysis this market is segmented on the basis of Hospitals sector and Orthopedic Clinics sector. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Orthobiologies Market and related technologies. 2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2025. 3) Identifications of new market opportunities and targeted promotional plans for Global Orthobiologies Market. 4) Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Orthobiologies Market are as follows:

The restraining factors of Global Orthobiologies Market are as follows:

Request Sample Report: https://www.marketresearchengine.com/orthobiologics-market

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Orthobiologics Market, By Product

7 Orthobiologics Market, By Application

8 Orthobiologics Market, By End User

9 Orthobiologics Market, By Region

10 Competitive Landscape

11 Company Profiles

11.1 Depuy Synthes (A Subsidiary of Johnson & Johnson)

11.2 Medtronic PLC.

11.3 Stryker Corporation

11.4 Zimmer Biomet Holdings, Inc.

11.5 Harvest Technologies Corporation (A Terumo Bct Company)

11.6 Globus Medical, Inc

11.7 Orthofix International N.V.

11.8 RTI Surgical, Inc

11.9 K2M Group Holdings, Inc

11.10 Kuros Biosciences Ltd.

11.11 Bioventus LLC

11.12 Nuvasive, Inc.

11.13 Seaspine Holdings Corporation

11.14 Arthrex, Inc

11.15 Xtant Medical Holdings, Inc

Other Related Market Research Reports:

Nitrogenous Fertilizers Market is Expected to Exceed US$ 127.00 Billion By 2022

Organ Preservation Solutions Market is Supposed to Reach US$ 300 Million By 2023

Phosphate Esters Market Size is Projected to be Around US$ 1,180.0 Million By 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [emailprotected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

See the original post here:
Orthobiologics Market 2019 | How The Industry Will Witness Substantial Growth In The Upcoming Years | Exclusive Report By MRE - Cole of Duty

Stem Cell Therapy Market Share Research By Applications And Regions – News.MarketSizeForecasters.com

The study titled Global Stem Cell Therapy Market Research Report includes detailed research undertaken by analysts as well as an in-depth analysis of the global market. A detailed, highly extensive study of this market alongside pivotal aspects that may impact the commercialization graph of this industry has been given in the study.

As per the latest research report, the global Stem Cell Therapy Market is anticipated to depict a CAGR of 10.2% through 2025, having recorded a valuation of 7.8 billion in 2018.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/3331

By 2025, the Stem Cell Therapy Market is expected to hit a remuneration of 15 billion. An extremely definite evaluation of the global market in terms of qualitative as well as quantitative analysis has been covered in this report. The myriad aspects of this industry, having considered its historical and forecast data have been enlisted in the study. Also, the research report is inclusive of substantial details with regards to an efficient SWOT analysis, PESTEL analysis, and Porters five force model of the market.

The Stem Cell Therapy Market report coverage includes numerous aspects like the market size, geographical growth opportunities, important vendors in the market, driving factors and constraints, segmental evaluation, and competitive landscape.

The report intends to enlist myriad updates and data with regards to the market alongside various growth opportunities which may help the global industry expand at an appreciable rate. An in-depth summary of the Stem Cell Therapy Marketcombined with a well-defined set of market definitions as well as outline of the industry have been given in the report.

In the report, the abstract section is inclusive of information on the market dynamics. This section is further categorized into driving factors propelling the market growth, industry hindrances, trends characterizing the market growth, as well as the business opportunities prevalent in the industry.

The Stem Cell Therapy Market report also contains information pertaining to the anticipated CAGR of the global business through the forecast period. In addition, many technological developments and innovations that may possibly boost the industry outlook over the anticipated period are also mentioned in the study.

Top Companies

Split by application, the market is divided into

This study is inclusive of in-depth information with respect to the consumption of the product as well as application segment market share, in tandem with the growth rate likely to be registered by every application segment.

Report Growth Drivers

What are the key highlights of this report?

More here:
Stem Cell Therapy Market Share Research By Applications And Regions - News.MarketSizeForecasters.com

Biopreservation Market Worth $4.9 Billion by 2025 | Key Players Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Avantor, Inc. (US) -…

ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions, Inc. (US), Exact Sciences Corporation (US), (US), Worthington Industries, Inc. (US), and Chart Industries, Inc. (US) are some key players in Biopreservation Market.

Therapeutic applications held the largest share of the biopreservation media and equipment market, by application.

According to the new market research reportBiopreservation Market by Type (Media (Sera), Equipment (Thawing Equipment, Alarms, Freezers)), Biospecimen (Human Tissue, Stem Cells, Organs), Application (Therapeutic, Research, Clinical Trials), End User (Hospitals, Biobank) Global Forecast to 2025, published by MarketsandMarkets, the Biopreservation Market is projected to reachUSD 4.9 billionby 2025 fromUSD 3.1 billionin 2020, at a CAGR of 9.1% between 2020 and 2025.

Increasing R&D investments, advances in biobanking and the growing trend of conserving cord blood stem cells of newborns, rising investments in regenerative medicine research, and the increasing demand for personalized medicine are the major factors driving the growth of the biopreservation media and equipment market.

The biopreservation media segment accounted for the largest share of the biopreservation media and equipment market.

Based on type, the biopreservation media and equipment market is segmented into biopreservation media and equipment. The biopreservation media segment accounted for the largest share of the global biopreservation media and equipment market in 2019. The large share of this segment is attributed to the increasing research activities in stem cell therapy, regenerative medicine, and personalized medicine.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=842

The human tissue samples segment accounted for the largest share of the biopreservation media and equipment market in 2019.

On the basis of biospecimen, the biopreservation media and equipment market is segmented into human tissue samples, organs, stem cells and other biospecimens. The human tissue samples segment accounted for the largest share of the global biopreservation media and equipment market in 2019. The large share of this segment is attributed to the increasing number of biobanks and growth in R&D spending for life science research.

North Americato dominate the biopreservation media and equipment market during the forecast period

In 2019,North Americadominated the biopreservation media and equipment market, followed byEurope. The major factors driving the growth of this market include increasing research activities in the field of regenerative medicine, rising R&D investment in life sciences research and growing awareness of personalized medicine.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=842

The prominent players in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Avantor, Inc. (US) ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions, Inc. (US), Exact Sciences Corporation (US), (US), Worthington Industries, Inc. (US), and Chart Industries, Inc. (US).

Media Contact

Company Name: MarketsandMarkets

Contact Person: Mr. Aashish Mehra

Email: Send Email

Phone: 18886006441

Address: 630 Dundee Road Suite 430

City: Northbrook

State: IL 60062

Country: United States

Website: https://www.marketsandmarkets.com/Market-Reports/biopreservation-media-storage-equipment-market-842.html

Read more from the original source:
Biopreservation Market Worth $4.9 Billion by 2025 | Key Players Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Avantor, Inc. (US) -...

In the middle of a pandemic, a young Minnesota mother fights her second cancer diagnosis – Minneapolis Star Tribune

By and photos by alex kormann Star Tribune

June 27, 2020 7:05am

Taylor Bustos rubbed her newly shaved head in the dimly lit basement of her temporary Rochester home as an intrepid thought seized her. This better freaking be the last time.

Two years ago, Bustos was happy. She was 20, recently married and had just found out she was pregnant with her first child. Taylor and her husband, Mark, 21, envisioned moving from Duluth to California and raising half a dozen kids. But those plans would have to wait.

Five months into her pregnancy, Bustos felt a lump on her neck. On Oct. 5, 2018, just a month after giving birth to her son, Solomon, she was diagnosed with nodular sclerosis classical Hodgkins lymphoma. Its the most common type of Hodgkins lymphoma, a cancer that affects the bodys immune system.

Go here to read the rest:
In the middle of a pandemic, a young Minnesota mother fights her second cancer diagnosis - Minneapolis Star Tribune

Over 2,000 patients get stem cell treatment for COVID-19 in UAE | MEO – Middle East Online

ABU DHABI - The Abu Dhabi Stem Cell Centre (ADSCC) has treated more than 2,000 patients suffering from COVID-19, with 1200 already fully recovered from the effects of the virus, according to state news media agency WAM.

ADSCC announced that it had succeeded in ramping up the number of treatments from the 73 in the initial clinical trial.

The large increase was due to a major effort by staff at the centre to treat as many people as possible following the UAE governments decision to make it available free of charge to all moderate-to-high risk COVID-19 patients in the Gulf state.

The Governments decision came after the treatment, which is branded UAECell19, showed efficacy and an impressive safety profile reflected in the absence of significant changes in adverse events reported, an absence of any unexpected serious reactions (such as anaphylaxis, allergic reactions or sudden death) and an absence of any lung complications as determined by radiological exams from inhalation of the nebulized product.

A team of doctors and researchers at ADSCC, led by Dr Yendry Ventura, announced in May they had developed a new treatment for COVID-19 patients.

UAECell19, an autologous stem cells based therapy, appears to help the body fight the virus and makes the disease less harmful.

Following an initial trial, researchers were able to conclude that UAECell19 reduced the duration of hospitalization from 22 days to just six, when compared to patients who had received standard treatment.

Further analyses revealed that patients treated with the stem cells were 3.1 times more likely to recover in less than seven days than those treated with standard therapy, and 67% of the patients who received the stem cells treatment owed this recovery to the new treatment.

ADSCC has since secured intellectual property rights protection for UAECell19, which opens the way for the treatment to be shared widely so more patients can benefit.

ADSCC said researchers were at various stages of several investigatory efforts to establish effectiveness (Phase 3 trial), optimal efficacy of dosage, and efficacy to treat other respiratory diseases such asthma, COPD, and cystic fibrosis.

Read more here:
Over 2,000 patients get stem cell treatment for COVID-19 in UAE | MEO - Middle East Online

Six-year-old given heroes welcome by his classmates after months of life-saving cancer treatment in Singapore – Yahoo Finance UK

A six-year-old who won the nations hearts in his battle with leukaemia has been given a heroes welcome after flying home following months of life-saving cancer treatment in Singapore.

Brave Oscar Saxelby-Lee from St Johns, Worcester, was diagnosed with an aggressive blood cancer in December 2018 after his parents noticed unusual bruising on his legs.

Doctors gave him months to find a stem cell match to save his life which led to parents Olivia Saxelby, 25, and Jamie Lee, 28, launching a UK-wide appeal for donors.

Last March a record-breaking 4,855 volunteers queued in the freezing rain after Oscars primary school in opened as a testing centre.

In total more than 10,000 people were tested across the UK until a match was finally found.

Read more: Mum-to-be plagued by headaches diagnosed with incurable brain tumour

But just months later, the family faced further anguish after discovering Oscars cancer had returned.

After a crowdfunding campaign raised 600,000, Oscar was flown to Singapore for pioneering treatment not available on the NHS.

Oscar became only the second child in the world to undergo CAR-T therapy before having a second bone marrow transplant using stem cells from dad Jamie.

Oscar Saxelby-Lee, with his mum and dad during his time having treatment in Singapore. (SWNS)

Just three months after the successful operation, Oscar and his parents were given the all clear to return to the UK and hours after touching down he was driven see his classmates, who cheered as he drove past the school gates.

In heartwarming pictures Oscar grins from ear to ear as his proud dad sits next to him and his mum breaks down in tears of joy.

Pupils gave Oscar a huge bunch of colourful balloons which the youngster struggled to fit inside the car.

Read more:Woman diagnosed with cancer 48 hours before giving birth

Jen Kelly, from the Grace Kelly Trust which helped raise 173,000 to fund his life-saving treatment, said: The Grave Kelly Trust is delighted to see Oscar returning home to the UK with his mum and dad.

Out smiles have been growing ever wider as we watched Oscars miraculous journey.

We are so proud to have been able to play a key part in Oscars bid for life-saving treatment in Singapore and it is wonderful to see Oscar doing so well following his ground-breaking treatment.

This news is amazing, not just for Oscar, but potentially for other children in a similar position in the future.

Oscar still has a way to go and will need to be shielded for a good while longer once he gets home, but he remains cancer free and smiling.

Read more:Parents spot cancer in babys eye after photo taken

Oscar leaves Hospital in Singapore. (SWNS)

Story continues

Throughout his treatment, Oscar has kept in touch with his classmates and teachers from his hospital bed via an innovative robot - nicknamed Ozzybot.

His headteacher Kate Wilcock, who organised the huge donor registration event and Ozzybot lessons, said: There have been plenty of ups and downs to get here but this is the absolute icing on the cake that hes come home, cancer free and its worked.

Our future plans now will be to support Oscar and his family and even start some learning at home.

Then we will be working really closely with Olivia, Jamie and Oscar for some transition into school.

That will be the best day when he walks back through the door at Pitmaston Primary.

Oscar made a surprise visit to his classmates on his return from Singapore. (SWNS)

When he left hospital for the final time in Singapore Ozzy, as he is affectionately nicknamed, was given a guard of honour by medical staff.

A video posted on the Hand in Hand for Oscar Facebook page, shows the youngster beaming as he is driven away and shouts: Bye hospital, thank you!

Read more: Six-year-old runs marathon for the NHS dressed as his favourite super-heroes

His thrilled mum Olivia wrote: Cant quite believe it, crying bucket loads! The day weve dreamt of has now become a reality!

Were actually bringing him home!!!

You are our HERO Ozzy Bear, you truly truly are the most amazing miracle.

Enjoy every last minute of this journey darling, because YOU have owned [sic] it!

Additional reporting SWNS.

Follow this link:
Six-year-old given heroes welcome by his classmates after months of life-saving cancer treatment in Singapore - Yahoo Finance UK